THEOPHYLLINE

Generic: THEOPHYLLINE

Ajanta Pharma USA Inc.Manufacturer
ORALRoute
THEOPHYLLINE ANHYDROUSActive Substance
2025-01-13Original Approval

THEOPHYLLINE is FDA application ANDA218401, sponsored by AJANTA PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DYSPNOEA
2,461 reports
2
ASTHMA
2,128 reports
3
PNEUMONIA
1,492 reports
4
WHEEZING
1,458 reports
5
VOMITING
1,266 reports
6
COUGH
1,128 reports
7
DRUG HYPERSENSITIVITY
990 reports
8
MALAISE
837 reports
9
OEDEMA
815 reports
10
DRUG INEFFECTIVE
807 reports